TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair TELA Bio, Inc. - GlobeNewswire - Tue Jun 3, 3:05PM CDT ...

MALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today ...

OviTex Inguinal is available in two configurations in Europe, consisting of a three- or four-layer anatomically shaped device, to provide surgeons with a variety of options to address unique patient, ...

The study, led by Dr. Paul Szotek, Medical Director of the Indiana Hernia Center, included the analysis of 259 patients who underwent robotic inguinal hernia TAPP repair using the ReBAR technique and ...

OviTex Inguinal will be showcased this week at the European Hernia Society (EHS) Annual Congress in Paris, France, where the TELA Bio team will highlight the product’s design features and ...

The study, led by Dr. Paul Szotek, Medical Director of the Indiana Hernia Center, included the analysis of 259 patients who underwent robotic inguinal hernia TAPP repair using the ReBAR technique ...

Based on market research, inguinal hernia repair is the most common type of hernia repairMALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical ...

Based on market research, inguinal hernia repair is the most common type of hernia repairMALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical ...